Contracts › HT942525C0029
HT942525C0029: Dha Phase Ii Sbir Contract for Psoralen-Uv-A Inactivation Based High-Throughput Pathogen Inactivation Device
Awarded to Tda Research, Inc. by Defense Health Agency.
$1.3Mobligated
$1.3Mpotential value
10 November 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | HT942525C0029 |
|---|---|
| Awardee | Tda Research, Inc. |
| Awarding agency | Defense Health Agency |
| Awarding office | DEFENSE HEALTH AGENCY |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | CO |
| Offers received | 3 |
| Period of performance | 11 July 2025 to 10 November 2027 |
| Potential end | 10 November 2027 |
| Estimated recompete solicitation | ~Q2 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record